scorecardresearch
Friday, September 12, 2025
TopicAstraZeneca

Topic: AstraZeneca

5 sites in India ready for final phase of human trials of Oxford-AstraZeneca Covid vaccine

The Serum Institute of India will start manufacturing the vaccine even before the final nod so it is ready with sizeable volumes once the vaccine gets all permissions.

India to give 60 of 140 patients for clinical trial of cancer drug Acalabrutinib for Covid

The drug, branded as Calquence by AstraZeneca, has improved clinical outcomes of patients with severe Covid-19, according to a peer-reviewed study.

AstraZeneca-Gilead deal might not actually happen, say analysts

Political opposition from both Britain and America could derail any attempt at a deal, especially given the backdrop of the Covid-19 outbreak.

Why AstraZeneca is pondering a $240 billion gamble with Gilead

Combining the science teams of two pharma giants ought to aid future drug discovery. But it's still not clear if either side needs this deal.

Big pharma is looking beyond coronavirus with AstraZeneca eyeing merger with Gilead

The suggestion of a blockbuster merger between the two drugmakers is a sign that the industry is getting back to something resembling business as usual.

AstraZeneca’s cancer drug shows early signs of promise in treating severe Covid cases

The results, published in Science Immunology, are promising enough for AstraZeneca to launch the second phase of the trial, which will involve 200 patients.

Why AstraZeneca needs to avoid getting sucked into ‘vaccine nationalism’

AstraZeneca is indicating it can meet orders for its Covid vaccine from various countries simultaneously. It’s a laudable aspiration that needs to be achieved.

On Camera

Coup, conspiracy & the foreign hand—What Indian TV news channels saw in Nepal this week

‘Gen Z v/s Govt’ TV news coverage went for two days—not sure about the source of the telecast from Kathmandu since no credit was given.

What’s behind bond yields’ logic-defying spike? The market’s concern over the future

While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.

Navy gets first Tata-made Spanish 3D surveillance radar for its warships, 19 more to come

It is one of the most advanced long-range air defence and anti-missile radars. It has been acquired under an about USD 145-million deal signed in 2020.

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?